Eligo Bioscience
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$65.34M
Company Overview
Eligo Bioscience is a biotechnology company that develops in vivo gene editing technologies to modulate the microbiome for the treatment of bacteria-associated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eligo Bioscience Comparables
Compare Eligo Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SNIPR Biome | 88% | |
| Locus Biosciences | 85% | |
| Nemesis Bioscience | 83% |
Eligo Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Series B | Dec 5, 2023 | ||||
| Grant | May 1, 2019 | ||||
| Series A | Sep 26, 2017 | ||||
| Seed | Jul 8, 2015 |
Key People
Founding team and executive leadership
Eligo Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series B, Series A |
| European Commission | Grant |
| Government of France | Grant |
| Sanofi Ventures | Series B |
| Bpifrance | Series B, Grant |
| Seventure Partners | Series A, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Recognized as one of the World Economic Forum’s 30 Most Innovative Companies.
- May 13, 2025
Partnered with Biose Industries for microbial fermentation.
Eligo Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eligo Bioscience's valuation, stock price, and market status.
Is Eligo Bioscience a public or private company?
Eligo Bioscience is a private company.
What is the current stock price of Eligo Bioscience?
Eligo Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Eligo Bioscience worth (valuation)?
Valuation information for Eligo Bioscience is not publicly available.
Can I buy Eligo Bioscience stock?
Eligo Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Eligo Bioscience's last funding round?
Eligo Bioscience's most recent funding round was Grant on May 13, 2025.
Who are the main investors in Eligo Bioscience?
Key investors in Eligo Bioscience include Khosla Ventures, Sanofi Ventures, Seventure Partners.
Will Eligo Bioscience IPO soon?
No public IPO plans have been announced for Eligo Bioscience.
How can I track Eligo Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eligo Bioscience's secondary market activity and sign up for updates.